Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

To be 17 again--anti-interleukin-17 treatment for psoriasis.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
Acquired immune demyelinating neuropathies.
Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by cirrus and spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Laminar cortical damage in multiple sclerosis.
Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study.
Tribute to John F. Kurtzke, MD, FACP, FAAN: 1926-2015.
Cladribine: mode of action and implications for treatment of multiple sclerosis.
Platelets and autoimmunity.
Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.
Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler.
Multiple sclerosis: Effect of smoking on antibody response to IFN-β treatment.
Improving the quality of mental health care in Multiple Sclerosis.
Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version.
Patients' perspectives on quality of mental health care for people with MS.
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Multiple sclerosis and family planning.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.
Validation of the Social Provisions Scale in People With Multiple Sclerosis.

Pages